DaVita (DVA) Stock Price

DaVita Price

🇺🇸NYSE·CLOSED
198.19USD
Market closed
Today +/-
Today %

DaVita (DVA) Stock | ISIN US23918K1088 | WKN 897914. The current DaVita stock price is 198.19 USD (2026). Revenue is 14.16 B USD. Net income is 1 B USD. The P/E ratio is 14.98. Market capitalization is 15.04 B USD. DaVita operates in the Health sector.

DaVita stock price

Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of DaVita over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how DaVita stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing DaVita's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

DaVita Stock Price History
DateDaVita Price
Access this data via the Eulerpool API

DaVita Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
4.88 B USD
737 M USD
290 M USD
Jan 1, 2007
5.26 B USD
853 M USD
382 M USD
Jan 1, 2008
5.66 B USD
868 M USD
374 M USD
Jan 1, 2009
6.1 B USD
938 M USD
422 M USD
Jan 1, 2010
6.22 B USD
985 M USD
406 M USD
Jan 1, 2011
6.73 B USD
1.15 B USD
478 M USD
Jan 1, 2012
8.19 B USD
1.37 B USD
536 M USD
Jan 1, 2013
11.76 B USD
1.86 B USD
633 M USD
Jan 1, 2014
12.8 B USD
1.81 B USD
723 M USD
Jan 1, 2015
13.78 B USD
1.86 B USD
270 M USD
Jan 1, 2016
10.71 B USD
1.68 B USD
880 M USD
Jan 1, 2017
10.88 B USD
1.62 B USD
664 M USD
Jan 1, 2018
11.41 B USD
1.49 B USD
159 M USD
Jan 1, 2019
11.39 B USD
1.76 B USD
811 M USD
Jan 1, 2020
11.55 B USD
1.68 B USD
774 M USD

DaVita Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 5:52 PM
 
REVENUE (M USD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M USD)
NET INCOME (M USD)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales DaVita generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue DaVita retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare DaVita's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares DaVita has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against DaVita's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

DaVita stock margins

The DaVita margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DaVita. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DaVita.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
30.53 %
15.1 %
5.94 %
Jan 1, 2007
31.8 %
16.2 %
7.26 %
Jan 1, 2008
30.74 %
15.34 %
6.61 %
Jan 1, 2009
30.47 %
15.37 %
6.92 %
Jan 1, 2010
28.81 %
15.84 %
6.53 %
Jan 1, 2011
31.16 %
17.02 %
7.1 %
Jan 1, 2012
31.8 %
16.7 %
6.55 %
Jan 1, 2013
30.31 %
15.77 %
5.38 %
Jan 1, 2014
28.73 %
14.14 %
5.65 %
Jan 1, 2015
28.71 %
13.48 %
1.96 %
Jan 1, 2016
30.6 %
15.71 %
8.22 %
Jan 1, 2017
29.76 %
14.89 %
6.1 %
Jan 1, 2018
28.14 %
13.06 %
1.39 %
Jan 1, 2019
30.51 %
15.41 %
7.12 %
Jan 1, 2020
30.84 %
14.58 %
6.7 %

DaVita Stock Revenue, EBIT, Earnings per Share

The DaVita earnings per share therefore indicates how much revenue DaVita has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2006
23.02 USD
3.48 USD
1.37 USD
Jan 1, 2007
24.48 USD
3.97 USD
1.78 USD
Jan 1, 2008
26.7 USD
4.09 USD
1.76 USD
Jan 1, 2009
29.33 USD
4.51 USD
2.03 USD
Jan 1, 2010
30.19 USD
4.78 USD
1.97 USD
Jan 1, 2011
34.88 USD
5.94 USD
2.48 USD
Jan 1, 2012
41.77 USD
6.97 USD
2.73 USD
Jan 1, 2013
54.72 USD
8.63 USD
2.94 USD
Jan 1, 2014
58.96 USD
8.34 USD
3.33 USD
Jan 1, 2015
63.81 USD
8.6 USD
1.25 USD
Jan 1, 2016
52.23 USD
8.2 USD
4.29 USD
Jan 1, 2017
56.95 USD
8.48 USD
3.48 USD
Jan 1, 2018
66.31 USD
8.66 USD
0.92 USD
Jan 1, 2019
73.95 USD
11.4 USD
5.27 USD
Jan 1, 2020
93.91 USD
13.69 USD
6.29 USD

DaVita business model & stock analysis

DaVita Inc. is a company headquartered in Denver, Colorado, specializing in the provision and management of outpatient dialysis treatments (renal replacement therapy) and related services. The company was founded in 1999 and has since experienced impressive growth, with a presence in over ten countries worldwide. The history of DaVita traces back to the origin of its business model: outpatient dialysis treatment. This is a form of renal replacement therapy where patients can be treated outside of the hospital, in a dedicated center or even in their own homes. This type of dialysis is less intimidating compared to inpatient treatment in a hospital and can be much more flexible in terms of scheduling. DaVita took this idea and brought it to the market in the US and other countries, where it has proven to be extremely successful. Nowadays, DaVita operates in three main business segments. The first is the patient care segment, which focuses on providing dialysis treatments and related services. Here, DaVita offers outpatient dialysis centers where patients can receive regular treatment. Another important aspect of this segment is patient and family education, integrating them into the treatment process and helping them lead as normal a life as possible. The second core area is the pharmaceutical supply business. DaVita has an extensive network of facilities and suppliers, as well as its own pharmacies where the necessary medications for dialysis patients are manufactured and stored. DaVita also handles billing with insurance and other payment entities to ensure seamless patient care. The third core area of DaVita is the international supply company. Here, DaVita offers its services in over ten countries worldwide, including Mexico, Colombia, Brazil, Saudi Arabia, and Canada. DaVita has steadily expanded its international business in recent years and aims to have a presence in even more countries in the future. But DaVita does not limit itself to these three core areas. The company is also known for its innovative research and development efforts aimed at improving the treatment of kidney disease and developing new technologies. Products offered by DaVita include innovative dialysis devices, advanced care management software, and intelligent sensors for automated patient monitoring. In its over 20-year history, DaVita has overcome many challenges, including regulatory issues, economic fluctuations, and ever-growing competition. Despite these challenges, the company has steadily expanded its position in the industry and established itself as a leading provider of dialysis and related services. DaVita's success is based on a culture of results orientation and a strong commitment to improving patient outcomes. The company understands that each patient has unique needs and that the treatment of kidney disease requires a lifelong commitment. Therefore, DaVita emphasizes individual care and collaboration with patients and their families to ensure optimal care. Overall, DaVita is an innovative company specializing in the provision of dialysis treatments and related services. The company has overcome many challenges in its history and established itself as a leading provider of dialysis and related services. DaVita is committed to improving the quality of life for dialysis patients worldwide and continuously optimizing the treatment of kidney disease.

DaVita SWOT Analysis

Strengths

1. Industry Leadership: DaVita Inc is one of the leading providers of kidney dialysis services in the healthcare industry.

2. Extensive Network: The company operates a vast network of dialysis centers across the United States and internationally.

3. High-Quality Care: DaVita is known for providing exceptional patient care and achieving positive patient outcomes.

Weaknesses

1. Legal and Regulatory Risks: The healthcare industry is subject to strict regulations, which may pose challenges to DaVita's operations.

2. Dependence on Medicare and Medicaid: A significant portion of DaVita's revenue comes from government-funded healthcare programs, making it vulnerable to changes in reimbursement policies.

3. Vulnerability to Litigation: DaVita has faced legal issues in the past, which can impact its reputation and financial performance.

Opportunities

1. Growing Demand for Dialysis Services: The increasing prevalence of chronic kidney disease presents an opportunity for DaVita to expand its customer base.

2. International Expansion: DaVita can explore new markets and expand its presence in countries with a significant need for dialysis services.

3. Technological Advancements: Embracing technological innovations in healthcare can enhance DaVita's operations and improve patient care.

Threats

1. Competitive Landscape: Other major players in the dialysis services industry pose a threat to DaVita's market share and profitability.

2. Pricing Pressure: Pricing pressures from insurance providers and government payers can impact DaVita's financial performance.

3. Economic Downturn: During economic downturns, individuals may delay or forgo non-essential medical treatments, which could affect DaVita's revenue.

DaVita Segments

DaVita Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

U S Dialysis
U.S. dialysis
Other - Ancillary services
Details
Date
U S Dialysis
U.S. dialysis
Dialysis And Related Lab Services
Guarantor Subsidiaries
Other - Ancillary services
Non-Guarantor Subsidiaries
DaVita Inc
Other Ancillary Services And Strategic Initiatives
Consolidating Adjustments
Jan 1, 2010
0 USD
0 USD
6.07 B USD
5.2 B USD
0 USD
1.29 B USD
431.78 M USD
374.5 M USD
-477.44 M USD
Jan 1, 2018
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
0 USD
Jan 1, 2019
0 USD
0 USD
0 USD
0 USD
957.9 M USD
0 USD
0 USD
0 USD
0 USD
Jan 1, 2020
0 USD
10.51 B USD
0 USD
0 USD
1.04 B USD
0 USD
0 USD
0 USD
0 USD
Jan 1, 2021
0 USD
10.58 B USD
0 USD
0 USD
1.04 B USD
0 USD
0 USD
0 USD
0 USD
Jan 1, 2022
0 USD
10.51 B USD
0 USD
0 USD
1.1 B USD
0 USD
0 USD
0 USD
0 USD
Jan 1, 2023
0 USD
10.85 B USD
0 USD
0 USD
1.29 B USD
0 USD
0 USD
0 USD
0 USD
Jan 1, 2025
11.73 B USD
0 USD
0 USD
0 USD
1.91 B USD
0 USD
0 USD
0 USD
0 USD

DaVita Revenue by Segment (2/3)

  • 3 Years

  • 5 Years

  • Max

U S Dialysis And Related Lab Services
Details
Date
U S Dialysis And Related Lab Services
Jan 1, 2010
0 USD
Jan 1, 2018
10.24 B USD
Jan 1, 2019
10.43 B USD
Jan 1, 2020
0 USD
Jan 1, 2021
0 USD
Jan 1, 2022
0 USD
Jan 1, 2023
0 USD
Jan 1, 2025
0 USD

DaVita Revenue by Segment (3/3)

  • 3 Years

  • 5 Years

  • Max

Other ancillary services and strategic initiatives
Details
Date
Other ancillary services and strategic initiatives
Jan 1, 2010
0 USD
Jan 1, 2018
1.16 B USD
Jan 1, 2019
0 USD
Jan 1, 2020
0 USD
Jan 1, 2021
0 USD
Jan 1, 2022
0 USD
Jan 1, 2023
0 USD
Jan 1, 2025
0 USD

DaVita Eulerpool Fair Value

DaVita historical P/E ratio, EBIT multiple, and P/S ratio

DaVita annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

DaVita shares outstanding

The number of shares was DaVita in 2025 — This indicates how many shares 75.885 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2006
212 M base_Shares
Jan 1, 2007
215 M base_Shares
Jan 1, 2008
212 M base_Shares
Jan 1, 2009
208 M base_Shares
Jan 1, 2010
206 M base_Shares
Jan 1, 2011
193 M base_Shares
Jan 1, 2012
196 M base_Shares
Jan 1, 2013
215 M base_Shares
Jan 1, 2014
217 M base_Shares
Jan 1, 2015
216 M base_Shares
Jan 1, 2016
205 M base_Shares
Jan 1, 2017
191 M base_Shares
Jan 1, 2018
172 M base_Shares
Jan 1, 2019
154 M base_Shares
Jan 1, 2020
123 M base_Shares
Price targets and forecasts for DaVita are not yet available.

DaVita Earnings Estimates

DaVita Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
4/30/20262.34USD3.39 BUSD2026 Q1
2/2/20263.19USD3.53 BUSD2025 Q4
5/6/20241.68USD3.01 BUSD2024 Q1
2/20/20241.58USD3.04 BUSD2023 Q4
7/31/20231.62USD2.97 BUSD2023 Q2
5/3/20231.22USD2.87 BUSD2023 Q1
2/8/20231.14USD2.98 BUSD2022 Q4
10/28/20221.78USD3.02 BUSD2022 Q3
8/1/20222.11USD2.98 BUSD2022 Q2
5/5/20221.89USD2.93 BUSD2022 Q1
...

EESG©

Eulerpool ESG Scorecard© for the DaVita stock

79/100
82
Environment
65
Social
89
Governance
E

Environment

20
Scope 1 - Direct Emissions59,569
Scope 2 - Indirect emissions from purchased energy206,214
Scope 3 - Indirect emissions within the value chain705,383
Total CO₂ emissions265,783
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees78
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

DaVita shareholder structure

% Name
41.85157%
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
5.57146%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
3.47683%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
2.87696%
Weschler (R Ted)
Weschler (R Ted)
2.75856%
State Street Investment Management (US)
State Street Investment Management (US)
1.769%
Invesco Capital Management LLC
Invesco Capital Management LLC
1.46232%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
1.44822%
Gates Capital Management, Inc.
Gates Capital Management, Inc.
1.31453%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
1.23968%
LSV Asset Management
LSV Asset Management
...

DaVita Executives and Management Board

JR

Mr. Javier Rodriguez

(54)

Chief Executive Officer, Director · since 2000

Compensation21.81 M USD
JA

Mr. Joel Ackerman

(60)

Chief Financial Officer, Treasurer

Compensation6.35 M USD
DM

Mr. David Maughan

(48)

Chief Operating Officer - Davita Kidney Care

Compensation4.93 M USD
KW

Ms. Kathleen Waters

(57)

Chief Legal and Public Affairs Officer

Compensation4.65 M USD
JH

Mr. James Hearty

(56)

Chief Compliance Officer

Compensation2.34 M USD

DaVita Supply Chain

Frequently asked questions about DaVita

The main competitors of DaVita Inc in the market include companies like Fresenius Medical Care Holdings, Inc. and American Renal Associates Holdings, Inc.

All fundamentals and in-depth analysis of DaVita

Our stock analysis for DaVita Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DaVita Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.